Rie Ito

Rie Ito

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2011 in Journal of Chromatography B
Verified
Journal Article
Closed access
RIRie Ito
Rie Ito
MUMasaru Ushiro
Masaru Ushiro
YTYuki Takahashi
Yuki Takahashi
KSKoichi Saito
Koichi Saito
TOTetsuo Ookubo
Tetsuo Ookubo
HNHiroyuki Nakazawa
Hiroyuki Nakazawa

26 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
NSNoah Sasa
Noah Sasa
TKToshihiro Kishikawa
Toshihiro Kishikawa
MMMasashi Mori
Masashi Mori
RIRie Ito
Rie Ito
YMYumie Mizoro
Yumie Mizoro
HIHidenori Inohara
Hidenori Inohara
Integration of human papillomavirus (HPV) into the host genome drives HPV-positive head and neck squamous cell carcinoma (HPV+ HNSCC). Whole-genome sequencing of 51 tumors revealed intratumor heterogeneity of HPV integration, with 44% of breakpoints subclonal, and a biased distribution of integration breakpoints across the HPV genome. Four HPV physical states were identified, with at least 49% of tumors progressing without integration. HPV integration was associated with APOBEC-induced broad genomic instability and focal genomic instability, including structural variants at integration sites. HPV+ HNSCCs exhibited almost no smoking-induced mutational signatures. Heterozygous loss of ataxia-telangiectasia mutated (ATM) was observed in 67% of tumors, with its downregulation confirmed by single-cell RNA sequencing and immunohistochemistry, suggesting ATM haploinsufficiency contributes to carcinogenesis. PI3K activation was the major oncogenic mutation, with JAK-STAT activation in tumors with clonal integration and NF-kappa B activation in those without. These findings provide valuable insights into HPV integration in HPV+ HNSCC.

1 July 2009 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
RIRie Ito
Rie Ito
NMNaoko Miura
Naoko Miura
MUMasaru Ushiro
Masaru Ushiro
MKMigaku Kawaguchi
Migaku Kawaguchi
HNHiroko Nakamura
Hiroko Nakamura
HNHiroyuki Nakazawa
Hiroyuki Nakazawa

14 June 2024 in Food Chemistry: X
Verified
Journal Article
Open access
ATAkira Torii
Akira Torii
YSYusuke Seki
Yusuke Seki
RSRyoichi Sasano
Ryoichi Sasano
YIYoshiki Ishida
Yoshiki Ishida
KNKosuke Nakamura
Kosuke Nakamura
HAHiroshi Akiyama
Hiroshi Akiyama
Rapid analysis of multiple food allergens is required to confirm the appropriateness of food allergen labelling in processed foods. This study aimed to develop a rapid and reliable method to simultaneously detect trace amounts of seven food allergenic proteins (wheat, buckwheat, milk, egg, crustacean, peanut, and walnut) in processed foods using LC-MS/MS. Suspension-trapping (S-Trap) columns and on-line automated solid-phase extraction were used to improve the complex and time-consuming pretreatment process previously required for allergen analysis using LC-MS/MS. The developed method enabled the simultaneous detection of selected marker peptides for specific proteins derived from seven food ingredients in five types of incurred samples amended with trace amounts of allergenic proteins. The limit of detection values of the method for each protein were estimated to be <1 mg/kg. The developed analytical approach is considered an effective screening method for confirming food allergen labelling on a wide range of processed foods.

10 August 2009 in Analytical Sciences
Verified
Journal Article
Open access
PDF file
RIRie Ito
Rie Ito
MKMigaku Kawaguchi
Migaku Kawaguchi
YKYouji Koganei
Youji Koganei
HHHidehiro Honda
Hidehiro Honda
NONoriya Okanouchi
Noriya Okanouchi
HNHiroyuki Nakazawa
Hiroyuki Nakazawa
A simple and highly sensitive method that involves miniaturized hollow fiber assisted liquid-phase microextraction (HF-LPME) with in situ acyl derivatization and GC-MS was developed for the determination of benzophenone (BP) and related compounds in human urine samples. The limits of detection (S/N = 3) and quantification (S/N > 10) of BPs in human urine samples are 0.01 to 0.05 and 0.05 to 0.2 ng ml−1, respectively. The average recoveries of BPs (n = 5) in human urine samples spiked with 10 and 50 ng ml−1 BPs are 93.1 to 106.7% (RSD: 1.5 to 8.4%) and 96.3 to 101.5% (RSD: 3.0 to 7.7%), respectively. When the proposed method was applied to human urine samples, BPs were detected at the sub ng ml−1 level.

1 January 2006 in BUNSEKI KAGAKU
Verified
Journal Article
Closed access
TKTsunenobu Katsumata
Tsunenobu Katsumata
ANAyako Nakata
Ayako Nakata
YIYusuke Iwasaki
Yusuke Iwasaki
RIRie Ito
Rie Ito
KSKoichi Saito
Koichi Saito
HNHiroyuki Nakazawa
Hiroyuki Nakazawa